Coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a scoping review

Objectives: To summarize published information on coagulation disorders in patients with SARS-CoV-2 infection, namely its characteristics, pathophysiology, diagnosis, and response to anticoagulant or antiplatelet therapy, either prophylactic or therapeutic.   Methods: A scoping review was conduct...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Susana Pereira Costa, Inês Lopes Antunes, Ana Margarida Gomes, Cláudia Ho, Mafalda Lemos Caldas, Ana Rute Marques, Ana Monteiro Pereira, Ana Teresa Peres, Gema Ponce Revilla, Inês Vidreiro
التنسيق: مقال
اللغة:English
منشور في: Associação Portuguesa de Medicina Geral e Familiar 2021-11-01
سلاسل:Revista Portuguesa de Medicina Geral e Familiar
الموضوعات:
الوصول للمادة أونلاين:https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13086
_version_ 1827313172979122176
author Susana Pereira Costa
Inês Lopes Antunes
Ana Margarida Gomes
Cláudia Ho
Mafalda Lemos Caldas
Ana Rute Marques
Ana Monteiro Pereira
Ana Teresa Peres
Gema Ponce Revilla
Inês Vidreiro
author_facet Susana Pereira Costa
Inês Lopes Antunes
Ana Margarida Gomes
Cláudia Ho
Mafalda Lemos Caldas
Ana Rute Marques
Ana Monteiro Pereira
Ana Teresa Peres
Gema Ponce Revilla
Inês Vidreiro
author_sort Susana Pereira Costa
collection DOAJ
description Objectives: To summarize published information on coagulation disorders in patients with SARS-CoV-2 infection, namely its characteristics, pathophysiology, diagnosis, and response to anticoagulant or antiplatelet therapy, either prophylactic or therapeutic.   Methods: A scoping review was conducted according to both Joanna Briggs Institute Guidelines on Scoping Reviews and Preferred Reporting Items for Systematic Reviews and Meta-Analyses Scoping Review guidelines (PRISMA-ScR). A search on the MEDLINE®, SciELO®, and Web of Science® databases was performed between the 1st and 2nd May 2020. The articles selection was divided into three sequential stages: based on title, on abstract, and full article reading. At each stage, articles were assessed against the inclusion and exclusion criteria and accepted or rejected accordingly. The data were then charted, and the relevant evidence was summarized. Results: After selection, 106 records were obtained. Of those, 36 corresponded to letters, 28 to original studies, 25 to reviews, and 14 to case reports; one metanalysis, one commentary, and one consensus paper were also included. Results have shown an association between COVID-19 and thrombotic complications, although different kinds of events and frequency rates were found. The triad inflammation, endothelial dysfunction, and coagulopathy seem to underly pathophysiological changes. Laboratory and imaging techniques may be useful for an adequate intervention. Prophylaxis with parenteral anticoagulants, preferably Low Molecular Weight Heparin (LMWH), in an intermediate dose between the commonly used ones for prophylaxis or treatment is indicated to hospitalized patients, especially those having a severe illness. It should be kept during a variable period after discharge, in an individualized patient-based approach. Therapeutical anticoagulation seems not to differ significantly from other disease settings.  Conclusions: Various uncertainties persist at coagulation disorders’ approach in patients with SARS-CoV-2 infection. The existing information has its origin mainly in the hospital setting and less robust sources. Thus, well-designed, randomized controlled clinical trials are needed to sustain clinical decisions at all stages.
first_indexed 2024-04-24T21:57:27Z
format Article
id doaj.art-0dd41d9f7afb4c33a734324045a2233b
institution Directory Open Access Journal
issn 2182-5181
language English
last_indexed 2024-04-24T21:57:27Z
publishDate 2021-11-01
publisher Associação Portuguesa de Medicina Geral e Familiar
record_format Article
series Revista Portuguesa de Medicina Geral e Familiar
spelling doaj.art-0dd41d9f7afb4c33a734324045a2233b2024-03-20T14:05:07ZengAssociação Portuguesa de Medicina Geral e FamiliarRevista Portuguesa de Medicina Geral e Familiar2182-51812021-11-0137510.32385/rpmgf.v37i5.13086Coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a scoping reviewSusana Pereira Costa0Inês Lopes Antunes1Ana Margarida Gomes2Cláudia Ho3Mafalda Lemos Caldas4Ana Rute Marques5Ana Monteiro Pereira6Ana Teresa Peres7Gema Ponce Revilla8Inês Vidreiro9USF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do TejoUSF Travessa da Saúde ACeS Loures-Odivelas ARS Lisboa e Vale do Tejo Objectives: To summarize published information on coagulation disorders in patients with SARS-CoV-2 infection, namely its characteristics, pathophysiology, diagnosis, and response to anticoagulant or antiplatelet therapy, either prophylactic or therapeutic.   Methods: A scoping review was conducted according to both Joanna Briggs Institute Guidelines on Scoping Reviews and Preferred Reporting Items for Systematic Reviews and Meta-Analyses Scoping Review guidelines (PRISMA-ScR). A search on the MEDLINE®, SciELO®, and Web of Science® databases was performed between the 1st and 2nd May 2020. The articles selection was divided into three sequential stages: based on title, on abstract, and full article reading. At each stage, articles were assessed against the inclusion and exclusion criteria and accepted or rejected accordingly. The data were then charted, and the relevant evidence was summarized. Results: After selection, 106 records were obtained. Of those, 36 corresponded to letters, 28 to original studies, 25 to reviews, and 14 to case reports; one metanalysis, one commentary, and one consensus paper were also included. Results have shown an association between COVID-19 and thrombotic complications, although different kinds of events and frequency rates were found. The triad inflammation, endothelial dysfunction, and coagulopathy seem to underly pathophysiological changes. Laboratory and imaging techniques may be useful for an adequate intervention. Prophylaxis with parenteral anticoagulants, preferably Low Molecular Weight Heparin (LMWH), in an intermediate dose between the commonly used ones for prophylaxis or treatment is indicated to hospitalized patients, especially those having a severe illness. It should be kept during a variable period after discharge, in an individualized patient-based approach. Therapeutical anticoagulation seems not to differ significantly from other disease settings.  Conclusions: Various uncertainties persist at coagulation disorders’ approach in patients with SARS-CoV-2 infection. The existing information has its origin mainly in the hospital setting and less robust sources. Thus, well-designed, randomized controlled clinical trials are needed to sustain clinical decisions at all stages. https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13086SARS virusBlood coagulation disordersAnticoagulantsPlatelet aggregation inhibitorsReview
spellingShingle Susana Pereira Costa
Inês Lopes Antunes
Ana Margarida Gomes
Cláudia Ho
Mafalda Lemos Caldas
Ana Rute Marques
Ana Monteiro Pereira
Ana Teresa Peres
Gema Ponce Revilla
Inês Vidreiro
Coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a scoping review
Revista Portuguesa de Medicina Geral e Familiar
SARS virus
Blood coagulation disorders
Anticoagulants
Platelet aggregation inhibitors
Review
title Coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a scoping review
title_full Coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a scoping review
title_fullStr Coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a scoping review
title_full_unstemmed Coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a scoping review
title_short Coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a scoping review
title_sort coagulation disorders in adults with severe acute respiratory syndrome coronavirus 2 sars cov 2 infection a scoping review
topic SARS virus
Blood coagulation disorders
Anticoagulants
Platelet aggregation inhibitors
Review
url https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13086
work_keys_str_mv AT susanapereiracosta coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT ineslopesantunes coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT anamargaridagomes coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT claudiaho coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT mafaldalemoscaldas coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT anarutemarques coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT anamonteiropereira coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT anateresaperes coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT gemaponcerevilla coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview
AT inesvidreiro coagulationdisordersinadultswithsevereacuterespiratorysyndromecoronavirus2sarscov2infectionascopingreview